Schedule I finds itself embroiled in copyright infringement allegations, yet in an unexpected twist, the accusing party's games are facing intense review-bombing from players. Discover the details of this copyright dispute along with Schedule I's forthcoming updates.
Schedule I Recent Updates
Developer Accusing Schedule I Faces Steam Review Backlash
The indie crime simulator Schedule I faces copyright infringement accusations from Movie Games S.A., creators of The Drug Dealer Simulator series. As reported by the Polish Press Agency on April 3, Movie Games S.A. claims their legal review suggests Schedule I allegedly copied gameplay elements, narrative structure, and UI design from their franchise.
While legal proceedings remain pending, gaming communities have swiftly taken sides—with overwhelming support favoring Schedule I. On Steam, The Drug Dealer Simulator titles now display "Overwhelmingly Negative" and "Mostly Negative" review scores following coordinated fan backlash.
Many negative reviews accuse Movie Games S.A. of hypocritical behavior, noting their silence toward similar games before Schedule I's successful Early Access launch. This controversy contrasts sharply with the series' prior acclaim as standout crime management simulations.
Schedule I offers a cooperative drug trade simulation where players evolve from street-level dealers into organized crime leaders. Since its March 25 Early Access debut, the game maintains "Overwhelmingly Positive" Steam ratings and ranks as Steam's #2 top-seller—surpassing anticipated titles like Monster Hunter Wilds and R.E.P.O. SteamDB records show Schedule I achieving 459,075 peak concurrent players.
At Game8, we found Schedule I delivers a compelling immersion into criminal empire-building—earning our praise as a standout "Breaking Bad" style experience. For our full analysis of its Early Access launch, explore our dedicated coverage below!
